In a breast cancer model, expansion of adoptively transferred tumor antigen-specific T cells was mediated by DC engagement through a combination therapy of Flt3L, radiotherapy, poly(I:C), and a CD40 agonist (176). Here, CD40 is linked to neoplasm.